$43.31 $0.45 per serving
Product analysis
Omega-3 Lemon offers good value for omega-3s and may modestly ease joint pain and stiffness. Benefits for routine skin improvement and a metabolic boost are less certain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The oil description identifies triglycerides, but ingredient-form details are not consistently clear. That limits a complete comparison of the ingredient profile.
Ingredient Transparency63
All listed amounts are disclosed. Forms are not clearly specified alongside those amounts, limiting a closer comparison.
Value For Money100
The cost is low relative to the EPA and DHA supplied. That gives it favorable value within the omega-3 comparison.
Customer Satisfaction97
Customer ratings are very positive across a large review base. The volume of feedback makes the satisfaction picture well established.
Product Focus76
Omega-3s may modestly help joint discomfort, with mixed results across conditions. Findings for metabolism and skin depend on particular populations or preparations, so broader benefits remain uncertain.
- Format
Liquid - Container
- 16 Fluid Ounce(s)
- Per serving
- $0.45
- Also available
Omega-3 Lemon$24.61- Customer rating
- 4.9 · 31,820 ratings
Goals
Impact
High effect
Omega-3 · 1560 mg
Omega-3 fatty acids are connected with skin lipids, and specific purified EPA preparations have been studied for responses to UV exposure. Those findings do not establish routine skin benefits from this product’s broad omega-3 declaration or a generic fish-oil amount. The serving amount does not establish the composition, frequency or duration used in those studies.
How this product is rated for Skin Health
Ingredient fit96
Omega-3 provides the main relevant connection in this formula. Its declared amount reaches the supplied comparison range.
Goal fit
Omega-3 provides a focused connection to the selected skin-health aspects.
Dose adequacy
Omega-3 reaches the supplied exposure reference, without proving additional skin benefit at that amount.
Pathways50
The supplied findings connect omega-3 with barrier lipids, although generic omega-3 amounts do not establish a tested skin intervention.
Depth
The strongest connection in the supplied findings is epidermal barrier lipids; this describes a mechanism, not a measured cosmetic result.
Breadth
One mechanism reaches the supplied coverage threshold, leaving the support focused.
Evidence78
Specific purified EPA has human UV-challenge evidence, but that preparation cannot be inferred from generic omega-3. The supplied preparation finding therefore has limited practical applicability.
Evidence strength
The human UV evidence uses specific purified EPA, so broad omega-3 does not establish the same intervention.
Studied preparation
The supplied preparation criterion is met, but generic omega-3 does not establish the purified EPA composition used in the cited skin research.
Formulation logic100
No required partner is missing and no specified formulation conflict is identified. This does not establish extra benefit from the combination.
Partner coverage
All counted ingredients work without an additional required partner or have that partner present.
Conflicts
No specified formulation conflict was matched in the supplied facts.
Effective doses
All ingredients counted for this finding clear its minimum exposure threshold, without establishing a clinically effective skin dose.
Impact
High effect
Omega-3 · 1560 mg
Omega-3 fatty acids may modestly ease joint pain and stiffness, particularly in inflammatory joint conditions; osteoarthritis results are mixed and several large trials found no benefit. The supplied serving contributes to this inflammation-related support, without establishing prevention or cartilage repair.
How this product is rated for Joint Health
Ingredient fit82
The counted declarations make partial amount contributions against the supplied references, without establishing equivalent clinical benefit.
Goal fit
The relevant ingredients keep the formula focused on joint support, although it is also linked to other goals.
Dose adequacy
The counted declarations make partial amount contributions against the supplied references, without establishing equivalent clinical benefit.
Pathways45
Omega-3 fatty acids provide the main inflammation-related joint contribution.
Depth
Omega-3 fatty acids provide the main inflammation-related joint contribution.
Breadth
Only the inflammation-related category reaches the saved breadth threshold; the other joint categories have no comparable contribution.
Evidence69
Omega-3 supplies the strongest evidence contribution, with small or inconsistent joint-symptom effects across different populations and preparations.
Evidence strength
Omega-3 supplies the strongest evidence contribution, with small or inconsistent joint-symptom effects across different populations and preparations.
Studied preparation
The saved finding accepts the omega-3 declarations, without establishing equivalence across every oil preparation or joint population.
Formulation logic100
The counted ingredients have no missing partner requirement, and no matched conflicts were identified. Their amounts meet the saved minimum criterion.
Partner coverage
The counted ingredients have no unmet partner requirement in the supplied findings; this does not establish added benefit from combining them.
Conflicts
No ingredient conflict was identified in the supplied findings.
Effective doses
All counted ingredients meet the saved minimum amount criterion, which is not a proven clinical-effect threshold.
Impact
Highest effect
Omega-3 · 1560 mg
Omega-3 findings for resting metabolic rate vary by population: a small study in older women found an increase, while a study in young men did not. This does not establish a routine metabolic boost for general users. The amount contributes to the saved comparison without establishing durable fat loss.
How this product is rated for Metabolism Support
Ingredient fit87
The recognized ingredients are relatively focused on the goal, though nutritional roles do not establish an extra metabolic boost. The supplied amounts contribute partly to the saved comparison; comparison amounts are not proven doses for increased energy expenditure.
Goal fit
The recognized ingredients are relatively focused on the goal, though nutritional roles do not establish an extra metabolic boost.
Dose adequacy
The supplied amounts contribute partly to the saved comparison; comparison amounts are not proven doses for increased energy expenditure.
Pathways48
Insulin sensitivity and metabolic hormones form the strongest recorded mechanism; biomarker changes do not prove greater calorie burning.
Depth
Insulin sensitivity and metabolic hormones form the strongest recorded mechanism; biomarker changes do not prove greater calorie burning.
Breadth
One mechanism reached the required coverage level, leaving the other mechanisms less represented.
Evidence89
Omega-3 leads the saved evidence finding; its supplied scientific limitations still apply to claims about metabolic rate.
Evidence strength
Omega-3 leads the saved evidence finding; its supplied scientific limitations still apply to claims about metabolic rate.
Studied preparation
The contributing preparations matched those recognized in the saved result, without establishing that the complete product reproduces a trial regimen.
Formulation logic100
No required partner or configured conflict reduced the recognized contributions. All counted amounts reached the minimum comparison threshold.
Partner coverage
No missing required partner reduced the recognized contributions; this does not establish additional benefit from combining ingredients.
Conflicts
No configured ingredient conflict was identified in the supplied calculation.
Effective doses
All counted ingredients reached the minimum comparison threshold, which is not a proven minimum dose for a metabolic boost.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 45 Calorie(s) | |
Total Fat | 5 Gram(s) | |
Cholesterol | 30 mg | |
Total Omega-3 Fatty Acids | 1560 mg |
Omega-3 · 1560 mg OverallScore84
A serving lists 745 mg EPA and 500 mg DHA in triglyceride form. The saved information reports third-party testing and certificates of analysis available on request.
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
The omega-3s are identified as triglycerides. An antioxidant and a source favored by the evaluation are recorded; this does not establish measured freshness.
Molecular Form & Absorption Potential
The omega-3s are identified as triglycerides, a form favored in the evaluation.
Source Purity & Oxidative Protection
An antioxidant and a source favored by the evaluation are recorded; this does not establish measured freshness.
Dose, Safety & Label Transparency61
A serving lists 745 mg EPA and 500 mg DHA. The oil concentration cannot be established from the saved facts.
EPA & DHA Label Specificity
A serving lists 745 mg EPA and 500 mg DHA separately.
Active Ingredient Concentration
The saved facts lack a usable total oil amount, so the share made up by EPA and DHA is unknown.
Third-Party Purity Verification
The saved information reports third-party testing and certificates of analysis available on request; those claims have not been independently verified here.
Value100
The price works out to about $0.37 per 1,000 mg of EPA and DHA combined.
Price per 1000mg of EPA+DHA
The price works out to about $0.37 per 1,000 mg of EPA and DHA combined.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
- Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
- Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
- Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
- A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
- Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
- Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
- Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
- The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
- A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial.
- Dietetic intervention in psoriatic arthritis: the DIETA trial.
- Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
- Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
- Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.